HomeCBI • TLV
add
Clal Biotechnology Industries Ltd.
Previous close
ILA 35.20
Day range
ILA 35.00 - ILA 36.50
Year range
ILA 29.00 - ILA 53.00
Market cap
56.31M ILS
Avg Volume
203.14K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(ILS) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.80M | -37.17% |
Net income | -20.63M | -1,801.48% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.71M | 36.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(ILS) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.54M | -9.33% |
Total assets | 107.32M | -44.96% |
Total liabilities | 24.38M | -40.52% |
Total equity | 82.94M | — |
Shares outstanding | 158.70M | — |
Price to book | 0.93 | — |
Return on assets | -4.19% | — |
Return on capital | -4.24% | — |
Cash Flow
Net change in cash
(ILS) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -20.63M | -1,801.48% |
Cash from operations | -1.59M | 12.66% |
Cash from investing | 8.27M | 122.00% |
Cash from financing | -6.29M | -1,136.64% |
Net change in cash | 504.50K | -67.21% |
Free cash flow | -2.12M | 16.07% |
About
Founded
1998
Website
Employees
3